pixlbio is redefining predictive biology.

Formed from the merger of DefiniGEN (UK) and Phenaros (Sweden), we combine iPSC-derived human models with high-throughput imaging and AI-powered phenomics to uncover subtle cellular insights that animal models can’t.

Our platform captures millions of images and profiles hundreds of millions of cells each week, turning complex biology into predictive clarity for drug discovery and safety.

What we offer:
- iPSC-derived hepatocytes, stellates & intestinal organoids
- Validated disease models (MASLD/MASH, A1ATD, Wilson’s)
- AI-driven phenomics
- Proprietary automation and SaaS access

Trusted by 11 of the top 20 pharma companies, leading biotechs, and research institutions worldwide.

We’re ISO 9001:2015 certified and expanding into cardiac and renal models — building the next generation of predictive biology.

✨ Every cell tells a story. Every pixel holds a clue.

pixlbio

Org chart

Teams

Offices

pixlbio

Org chart

Teams

Offices

Related companies